Trial Details
TERMINATEDBasic Information
| Clinical ID | c1090 |
|---|---|
| Identifier | NCT04987307 |
| Trial Title | Safety and Efficacy of Efavaleukin Alfa in Participants With Moderately to Severely Active Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Ulcerative Colitis |
| Interventions | DRUG: Efavaleukin alfa|DRUG: Placebo |
Participant Information
| Sponsor | Amgen |
|---|---|
| City | Dothan |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2022-01-31 |
|---|---|
| Primary Completion Date | 2024-10-22 |
| Completion Date | 2024-10-22 |